Georg Hansmannn

Lead Attending, Professor

Hannover Medical School

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Georg Hansmann is a Lead Attending Professor at Hannover Medical School in Germany. His research areas focus on cardiovascular health, particularly in the context of heart failure, pulmonary hypertension, and post-COVID syndrome. Recent publications highlight his work on fatty acid oxidation in heart failure, the effects of hypoxia on heart conditions, and innovative therapies for pediatric pulmonary arterial hypertension.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Laurent Calvier

University of Texas Southwestern Medical Center

UNITED STATES

View details

Brian Plouffe

Clincal Assistant Professor

University of Rhode Island

UNITED STATES

View details

Edgar Specker

Head of Core Facility

Leibniz-Forschungsinstitut für Molekulare Pharmakologie

GERMANY

View details

Lars Schwettmann

Head of Division Health Economics

Carl von Ossietzky Universität Oldenburg

GERMANY

View details

Gabor Kokeny

associate professor

Semmelweis University

HUNGARY

View details

Andreas W. Flemmer

Department Head

Ludwig-Maximilians-Universität München

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Georg Hansmannn

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression

Fatty acid oxidation is decreased in human right heart failure: Comment on Mendelson JB et al. Multi-omic and multispecies analysis of right ventricular dysfunction

Hypoxia Attenuates Pressure Overload-Induced Heart Failure

Multiparametric Cardiovascular MRI Assessment of Post-COVID Syndrome in Children in Comparison to Matched Healthy Individuals

Recovery of Biventricular Function After Catheter Intervention or Surgery for Neonatal Coarctation of the Aorta

Second International Pulmonary Hypertension/Heart Failure Symposium—Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network

Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia—A survey study in Germany (PUsH BPD)

Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β

Bilateral lung transplantation for pediatric pulmonary arterial hypertension: perioperative management and one-year follow-up

Can Mesenchymal Stem Cell–Derived Therapeutics Protect the Developing Brain During Cardiac Surgery?

Validation of the new paediatric pulmonary hypertension risk score by CMR and speckle tracking echocardiography

Echocardiographic Right Ventricular Wall Tension Indicates Disease Severity in Children With Pulmonary Arterial Hypertension

Atrial Flow Regulator for Postcapillary Pulmonary Hypertension

Human umbilical cord mesenchymal stem cell-derived treatment of severe pulmonary arterial hypertension

Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH

Letter by Legchenko et al Regarding Article, “Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure”

PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension

Collaborators (6)

Laurent Calvier

Brian Plouffe

Edgar Specker

Lars Schwettmann

Gabor Kokeny

Andreas W. Flemmer

Make your next move.